We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
726
DELISTED
Veren
VRN
| $750K | 0.03% |
+65,663
| New | +$922K |
|
727
Accuray
ARAY
$28M
| $748K | 0.03% |
+149,920
| New | +$963K |
|
728
Dana Inc
DAN
$2.9B
| $743K | 0.03% |
+46,843
| New | +$847K |
|
729
SLM Corp
SLM
$4.77B
| $743K | 0.03% |
+100,421
| New | +$885K |
|
|
CST
730
DELISTED
CST Brands, Inc.
CST
| $742K | 0.03% |
22,062
-6,619
| -23% | -$240K |
|
|
CNCE
731
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $741K | 0.03% |
+39,523
| New | +$672K |
|
732
Entegris
ENTG
$16.8B
| $740K | 0.03% |
+56,105
| New | +$774K |
|
733
Healthcare Services Group
HCSG
$1.59B
| $739K | 0.03% |
21,929
-6,127
| -22% | -$207K |
|
734
Standard BioTools
LAB
$321M
| $739K | 0.03% |
91,207
+72,539
| +389% | +$1.14M |
|
735
Bio-Rad Laboratories Class A
BIO
$8.81B
| $738K | 0.03% |
5,498
-2,986
| -35% | -$430K |
|
736
BioCryst Pharmaceuticals
BCRX
$2.44B
| $736K | 0.03% |
+64,625
| New | +$862K |
|
737
Columbia Sportswear
COLM
$3.21B
| $731K | 0.03% |
+12,451
| New | +$777K |
|
738
Magnite
MGNI
$2.83B
| $728K | 0.03% |
50,163
+13,832
| +38% | +$211K |
|
|
SAFE
739
Safehold
SAFE
$1.18B
| $728K | 0.03% |
+11,896
| New | +$745K |
|
|
BHR
740
Braemar Hotels & Resorts
BHR
$162M
| $727K | 0.03% |
+52,350
| New | +$746K |
|
|
SSRI
741
DELISTED
Silver Standard Resources
SSRI
| $727K | 0.03% |
111,568
+21,400
| +24% | +$130K |
|
742
OraSure Technologies
OSUR
$275M
| $725K | 0.03% |
163,486
+6,306
| +4% | +$32.9K |
|
|
RENT
743
DELISTED
RENTRAK CORP
RENT
| $725K | 0.03% |
+13,410
| New | +$753K |
|
|
TIF
744
DELISTED
Tiffany & Co.
TIF
| $723K | 0.03% |
9,372
-146,537
| -94% | -$12.8M |
|
745
CoreCivic
CXW
$3B
| $722K | 0.03% |
+24,467
| New | +$785K |
|
|
OSG
746
Octave Specialty Group
OSG
$257M
| $719K | 0.03% |
49,758
+17,447
| +54% | +$283K |
|
|
HEES
747
DELISTED
H&E Equipment Services
HEES
| $717K | 0.03% |
42,919
-62,218
| -59% | -$1.09M |
|
748
Portland General Electric
POR
$5.86B
| $716K | 0.03% |
19,369
-4,826
| -20% | -$170K |
|
|
SHOE
749
Shoe Station Group
SHOE
$414M
| $716K | 0.03% |
+60,184
| New | +$802K |
|
750
Pearson
PSO
$10.6B
| $715K | 0.03% |
41,699
+11,500
| +38% | +$208K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.